ApiFix Ltd.

ApiFix Ltd. developed the ApiFix procedure, a novel treatment option to fill a gap in the treatment of adolescent idiopathic scoliosis (AIS). The procedure offers select AIS patients a less-invasive, motion-preserving option for achieving curve correction. Since 2012, more than 500 AIS patients have been treated with the ApiFix procedure. ApiFix is a wholly owned subsidiary of OrthoPediatrics Corp. (Nasdaq: KIDS), focused exclusively on advancing the field of pediatric orthopedics and improving the lives of children with orthopedic conditions.